Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG").
i don’t think they would have done a full run unless they had most or all of the product pre-sold. i think the commercials sales PR is coming soon.
News 
Market Data 
Discover 
AI
